Skip to content

Compliance to Anti-Retroviral Therapy among African-Brazilians in Southern Brazil

Compliance to Anti-Retroviral Therapy among African-Brazilians in Southern Brazil - Compliance to Anti-Retroviral Therapy among African-Brazilians in Southern Brazil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001092
Enrollment
100
Registered
2008-03-26
Start date
2005-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV / AIDS

Interventions

Initial assessment while still in hospital during two interviews: 1. 1.1 Signature of the consent form 1.2 Test of knowledge about the research protocol 1.3 Demographics characteristics
#8776
60 minutes) or non-MATI conventional interview 2.2 Review of blood exams results 2.3 Scheduling of next collection of exams (CD4, viral load, genotyping) 2.4 Scheduling of the first outpati
QSCo Questionnaires Time 45 days Second outpatient appointment and research interview: 1) Presentation of exams (CD4, viral load, genotyping) 2) Guidelines form for conventional interview or MA

Sponsors

University of Caxias do Sul, Brazil
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: HIV infected patients admitted to the University of Caxias do Sul General Hospital due to Clinical complications of AIDS who will need Anti-Retroviral Therapy.

Exclusion criteria

Exclusion criteria: 1) Patients that don't have permanent abode or with localization's problems and accompaniment, or 2) Patients with physically or mental disturbs that can compromise the dislocation to research's places, or performance to participate about evaluations or logic and veracity of information (serious alterations of mental state).

Design outcomes

Primary

MeasureTime frame
To investigate if the Portuguese versions of the tested instruments present internal validity for future in Brazil. To investigate if different rates of compliance to anti-retroviral therapy are correlated to distinct immunologic and serologic paradigms.

Countries

South America

Contacts

Public ContactCarlos Zubaran

University of Caxias do Sul, Brazil The Biological and Health Sciences Center

zubaran_jr@yahoo.com555432182100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026